Related Experiment Videos
Monotherapy in children and infants.
1Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA. awilfong@bcm.edu
Neurology
|December 18, 2007
Summary
Selecting antiepileptic drugs (AEDs) for childhood epilepsy presents challenges. More research is needed to guide optimal treatment choices for pediatric patients, with the ketogenic diet as an alternative.
Area of Science:
- Pediatric Neurology
- Pharmacology
Background:
- An increasing number of antiepileptic drugs (AEDs) are available for childhood epilepsy.
- Treatment selection is complex due to factors like age-specific toxicity, cognitive/behavioral effects, and drug interactions in children.
Purpose of the Study:
- To review the challenges and considerations in selecting AEDs for pediatric epilepsy.
- To highlight the need for more research and discuss alternative treatments.
Main Methods:
- Review of current literature and guidelines on AED use in childhood epilepsy.
- Discussion of factors influencing treatment decisions in pediatric patients.
Main Results:
- Physicians face incomplete data for newer AEDs due to limited pediatric trials.
- Guidelines offer some strategies, but more randomized controlled trials (RCTs) are needed.
Conclusions:
- Optimizing AED therapy in childhood epilepsy requires careful consideration of individual patient factors.
- Further RCTs are essential for evidence-based treatment selection, and the ketogenic diet is a viable alternative for some children.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:21Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...